Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShield Thera Share News (STX)

Share Price Information for Shield Thera (STX)

Share Price is delayed by 15 minutes
Get Live Data
5.75    -0.10 (-1.71%)
Bid:
5.70
Ask:
5.80
Spread: 0.10 (1.754%)
Market Cap: £61.50m
STX Live PriceLast checked at - London Stock Exchange

Intraday Shield Thera Share Chart

IN BRIEF: Shield Therapeutics changes reporting currency to US dollars

Wed, 06th Sep 2023 20:33

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy for iron deficiency - Says it will change reporting currency to US dollars from pound sterling from 2023 results. Says the interim results for the first half of 2023 will include condensed and consolidated US dollar financial information for the period and full-year 2022.

Current stock price: 10.92 pence, up 1.6%

12-month change: down 14%

By Greg Rosenvinge, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

Related News

EARNINGS AND TRADING: ProService Building Services lowers outlook
1 May 2026

EARNINGS AND TRADING: ProService Building Services lowers outlook

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Friday and not separately reported...

LONDON MARKET MIDDAY: FTSE falls as US-Iran talks stall
1 May 2026

LONDON MARKET MIDDAY: FTSE falls as US-Iran talks stall

(Alliance News) - Stock prices in London were lower at midday on Friday, as hopes of diplomatic progress in the Middle East, and a batch of domestic d...

Shield Therapeutics reports positive Q1 earnings
1 May 2026

Shield Therapeutics reports positive Q1 earnings

(Sharecast News) - Shield Therapeutics reported first-quarter net revenue of $18m and positive EBIT on Friday, helped by a China milestone payment and...

Shield Thera News

IN BRIEF: Shield Therapeutics prescription orders up in first quarter
20 Jul 2023

IN BRIEF: Shield Therapeutics prescription orders up in first quarter

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy ...

IN BRIEF: Shield Therapeutics pretax loss doubles despite revenue rise
27 Apr 2023

IN BRIEF: Shield Therapeutics pretax loss doubles despite revenue rise

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy ...

IN BRIEF: Shield appoints Andy Hurley as chief commercial officer
5 Apr 2023

IN BRIEF: Shield appoints Andy Hurley as chief commercial officer

Shield Therapeutics PLC - Gateshead Quays, England-based commercial stage pharmaceutical company focused on the commercialisation of its oral therapy ...

AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages
9 Feb 2023

AIM WINNERS & LOSERS: Zytronic hit by electronic component shortages

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

Shield Therapeutics 2022 revenue jumps on Accrufer iron tablet sales
9 Feb 2023

Shield Therapeutics 2022 revenue jumps on Accrufer iron tablet sales

(Alliance News) - Shield Therapeutics PLC on Thursday said revenue in 2022 rose amid a jump in sales of its Accrufer iron tablets, also known as Ferac...

TRADING UPDATES: Mobile Tornado loses CEO; DeepVerge revenue jumps
9 Jan 2023

TRADING UPDATES: Mobile Tornado loses CEO; DeepVerge revenue jumps

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News:

Shield Therapeutics completes GBP2.6 million open offer
5 Jan 2023

Shield Therapeutics completes GBP2.6 million open offer

(Alliance News) - Shield Therapeutics PLC on Thursday said it has raised GBP2.6 million through an open offer.